ArticleCureus2026
Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome With Limited Systemic Sclerosis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune hepatitis-primary biliary cholangitis (AIH-PBC) overlap syndrome is an uncommon autoimmune liver disease, and its association with limited systemic sclerosis is rarely reported. We describe the case of a 41-year-old woman with a history of intrahepatic cholestasis of pregnancy (ICP) who presented with chronic pruritus, arthralgias, recurrent urinary tract infections, and Raynaud phenomenon. Laboratory evaluation demonstrated a predominantly cholestatic liver profile, positive antimitochondrial antibodies (AMAs), high-titer antinuclear antibodies (ANA) with a centromere pattern, elevated immunoglobulin G (IgG), and negative viral serologies. Imaging revealed cirrhotic liver morphology, splenomegaly, and features of clinically significant portal hypertension. Liver biopsy showed interface hepatitis with lymphoplasmacytic infiltrates, florid duct lesions, and ductopenia, supporting the diagnosis of AIH-PBC overlap syndrome in conjunction with the clinical and serological findings. Positive anticentromere antibodies confirmed limited systemic sclerosis. Despite treatment with ursodeoxycholic acid and immunosuppressive therapy, the patient experienced progressive liver dysfunction, developing decompensated cirrhosis with ascites and worsening portal hypertension, and is currently undergoing liver transplant evaluation. This case highlights the importance of recognizing extrahepatic autoimmune manifestations and integrating clinical, serological, and histopathological findings to establish an early diagnosis of AIH-PBC overlap syndrome associated with limited systemic sclerosis, allowing timely treatment and referral for liver transplantation in patients with progressive disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.